In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Past Working Group awardees

Pulmonary Circulation & Right Ventricular Function

During ESC Congress, the Working Group on Pulmonary Circulation and Right Ventricular Function awards 4 to 6 young researchers (under 36) who submitted the best abstracts on Pulmonary Hypertension/Circulation and the best abstracts on Pulmonary Embolism.

Abstracts ranking is based on the marks awarded by the ESC abstract reviewers and by the Working Group leadership.


Review all abstracts and presentations on ESC 365, the Cardiology Knowledge Hub.

Awardees 2020

Risa Ramadhiani: Endothelial cell premature senescence exacerbates pulmonary arterial hypertension through contact-mediated interaction with vascular smooth muscle cells

Chayakrit Krittanawong: A genome-wide association study identifies novel genetic loci associated with pulmonary embolism

Awardees 2019



  • Mehreen Batool (Cologne, DE) for the abstract on Vascular Diseases ‒ Hypertension, Pulmonary Hypertension:
    The six-transmembrane protein Stamp2 protects from hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension via actions in mononuclear cells and CXCL12
  • Ryo Kurosawa (Sendai, JP) for the abstract on Vascular Diseases ‒ Hypertension, Pulmonary Hypertension:
    Identification of celastramycin as a novel therapeutic agent for pulmonary arterial hypertension
  • Thomas Hofbauer (Vienna, AT) for the abstract on Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure – Pathophysiology and Mechanisms:
    Deficiency in milk fat globule-epidermal growth factor 8 delays thrombus resolution
  • Gusti Rizky Teguh Ryanto (Kobe, JP) for the abstract on Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure – Pathophysiology and Mechanisms:
    Inhibin Beta-A is a novel gene involved in the development of pulmonary arterial hypertension through inhibiting BMPRII-signaling in endothelial cells
  • Pamela Alarcon (Buenos Aires, AR) for the abstract on Pulmonary Embolism:
    Usefulness of different electrocardiographic patterns as predictors of in-hospital mortality in acute pulmonary embolism
  • Takahiro Hiraide (Tokyo, JP) for the abstract on Pulmonary Hypertension:
    Poor outcomes in pulmonary arterial hypertension as a member of RNF213-associated vascular diseases

Awardees 2018

  • Karl-Patrik Kresoja (Germany) for the abstract on Pulmonary Embolism:
    Predicting in-hospital major bleeding in pulmonary embolism patients treated with systemic thrombolytic therapy
  • Pedro Freitas (Portugal) for the abstract on Pulmonary Embolism:
    Derivation and external validation of a new score to predict pulmonary embolism related mortality and/or thrombolysis at 30-days
  • Ines Garcia Lunar (Spain) for the abstract on Pulmonary Hypertension:
    Effect of pulmonary artery denervation in a translational model of chronic postcapillary pulmonary hypertension
  • Pierre Guignant (France) for the abstract on Pulmonary Hypertension:
    Phenomapping for re-classification of patients with pulmonary hypertension at high risk

Awardees 2017

Irene Lang, Stephan Rosenkranz, Stefano Barco, Tatsuo Aoki, Karl-Patrik Kresoja, Taijyu Satoh, Barbara Girerd [left to right]

  • Tatsuo Aoki (Sendai, JP), for his abstract on Chronic pulmonary hypertension:
    Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension - long-term effects and complications
  • Stefano Barco (Mainz, GE), for his abstract on Acute pulmonary embolism:
    Determinants of the long-term haemodynamic course and late sequelae after acute intermediate-risk pulmonary embolism: results from a randomized thrombolysis trial
  • Barbara Girerd (Le Kremlin Bicêtre, FR), for her abstract on Pulmonary circulation:
    Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease
  • Aleksander Kempny (London, UK) for his abstract on Acute pulmonary embolism:
    Incidence of pulmonary embolism, associated mortality and bleeding risk in england between 1998-2015
  • Karl-Patrik Kresoja (Berlin, GE) for his abstract on Acute pulmonary embolism:
    Validation of the VTE-BLEED score for predicting 30-day major bleeding in a real-world cohort of patients with pulmonary embolism
  • Taijyu Satoh (Sendai, JP), for his abstract on Chronic pulmonary hypertension:
    Thrombin activatable fibrinolysis inhibitor promotes development of chronic thromboembolic pulmonary hypertension -A possible novel therapeutic target-

Awardees 2016

Stavros Konstantinides,  Sabina Rosset, Kenzo Ichimura, Max-Paul Winter,  Mona Sahlholdt Hansen, Irene Lang [left to right]









  • Erik Klok (Vienna, AT), for its abstract on Acute Pulmonary Embolism:
    Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation
  • Mona Sahlholdt Hansen (Aarhus N, DK), for its abstract on Right Ventricular Function:
    Levosimendan prevents and reverts pressure-overload induced right ventricular failure
  • Max-Paul Winter (Vienna, AT), for its abstract on Chronic Pulmonary Hypertension:
    A new experimental model of pulmonary arterial hypertension- KDR knock out
  • Kenzo Ichimura (Fukuoka, JP), for its abstract on Chronic Pulmonary Hypertension:
    Nanoparticle-mediated targeting of pitavastatin into small pulmonary arteries by intravenous administration attenuates the progression of monocrotaline-induced pulmonary arterial hypertension in rats
  • Sabina Rosset (Lausanne,CH), for its abstract on Chronic Pulmonary Hypertension:
    Severe ventricular interdependence as a cause of misclassification of group 2 pulmonary hypertension

Awardees 2015

Stavros Konstantinides, Mario Gerges, Irene Lang,  Erik Klok, Kasper Hasseriis Andersen, Hideya Shigyo [left to the right]









  • Mario Gerges (Vienna,AT) for its abstract on Right ventricular function:
    Combined pre and post-capillary pulmonary hypertension in chronic heart failure: epidemiology, right ventricular function and survival
  • Erik Klok (Leiden,NL) for its abstract on Acute pulmonary embolism:
    Withholding anticoagulation after negative CTPA is safe in patients with a likely clinical probability of PE
  • Hideya Shigyo (Suita,JP) for its abstract on Pulmonary circulation:
    Efficacy and safety of first-line oral triple upfront combination therapy in severe pulmonary arterial hypertension patients
  • Kasper Hasseriis Andersen (Copenhagen,DK) for its abstract on Chronic pulmonary hypertension:
    Venous remodelling in COPD pulmonary hypertension and idiopathic pulmonary arterial hypertension

Awardees 2014

4 Pulmonary Hypertension Awards (Unrestricted grant provided by Pfizer Limited):

  • Yaguo Zheng: Oral targeted therapies in the treatment of pulmonary arterial hypertension: a meta-analysis of clinical trials
  • Christian Gerges: Pulmonary artery occlusion waveform analysis for the assessment of pulmonary vascular disease in pulmonary hypertension due to left heart disease
  • Guido Claessen: Sildenafil increases stroke volume during exercise in patients with chronic thromboembolic pulmonary hypertension
  • Ana Garcia-Alvarez: Long-term oral B3-agonist treatment reduces pulmonary vascular resistance and improves right ventricular function in a swine model of chronic postcapillary pulmonary hypertension

2 Venous Thromboembolism Awards:

  • Erik Klok: Performance of five different bleeding-prediction scores in patients with acute pulmonary embolism
  • Anja Kaeberich: Optimized high sensitive troponin T cut-off values for risk stratification of normotensive patients with pulmonary embolism

Awardees 2013

2 Venous Thromboembolism Awards:

Delphine Baudouy: B blood type is a strong risk factor for venous thromboembolism recurrence
Mareike Lankeit: Angiopoietin-2 - a novel biomarker for risk stratification of acute pulmonary embolism

2 Pulmonary Hypertension Awards:

Max-Paul Winter: Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension
Jose Manuel Montero Cabezas: Demythologizing pulmonary artery aneurysm: prevalence and associated complications in a large pulmonary arterial hypertension population

Awardees 2012

Abstract: Plasma MR-proADM is superior to NT-proBNP for all-cause short term mortality prediction in acute pulmonary embolismby Justyna Pedowska-Wloszek
Abstract: Pulmonary embolism in Sweden, a national cohort and survival analysis, by Therese Anderson
Abstract: Right ventricular hypertrophy and failure abolish cardioprotection by ischemic preconditioning, by Asger Andersen
Abstract: Survival in pre-capillary pulmonary hypertension: does echocardiography make the difference?, by Julia Grapsa
Abstract: Egr-1 expression is specific for neointimal development in both human and experimental PAH, by Michael Dickinson
Abstract: Treatment of decompensated left-sided heart failure lowers right ventricular pulsatile load and increases the pulmonary arterial time constant, by Matthias Dupont

Awardees 2011

Abstract: Pulmonary arterial stroke volume: a new and strong prognostic factor in pediatric pulmonary arterial hypertension
by Johannes Menno Douwes (NL)
Abstract: Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension
by Barbara Girerd (FR)
Abstract: ESC-ERS 2009 pulmonary hypertension guidelines: an evaluation study in 9 European countries (the guide to PH study)
by Enri Leci (IT)
Abstract: Survival in patients with pulmonary arterial hypertension associated with connective tissue disease over the past decade
by Christopher Valerio (UK)
Abstract: Predictive value of the new highly sensitive troponin T assay compared to a clinical score in normotensive patients with acute pulmonary embolism: a prospective external validation study by Mareike Lankeit (DE)
Abstract: In-hospital major bleeding predicts mortality in patients with objectively confirmed pulmonary embolism
by Anna Budaj-Fidecka (PL)

Awardees 2010

Abstract: Prognostic value of echocardiographic parameters in patients with pulmonary arterial hypertension (PAH) treated with targeted therapies, by Elena Beciani
Abstract: Vardenafil in Pulmonary Arterial Hypertension: A Randomized, Double-blind, Placebo-controlled Study, by Zhi-Cheng Jing